Atlas Trials

A Study to Investigate the Effects of Imatinib on Pulmonary Vascular Dysfunction in a Human Model of Lung Injury

Clinical trial NCT03328117 · COMPLETED

Trial details

NCT number
NCT03328117
Sponsor
Exvastat Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Lung Injury
Start date
2017-11-13
Primary completion
2018-03-05
Enrollment
47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.